subtenon's: Peribulbar Block Versus Subtenon's Injection in Redo Vitreoretinal Surgery

Sponsor
Abeer Samir Salem (Other)
Overall Status
Recruiting
CT.gov ID
NCT04978415
Collaborator
Research Institute of Ophthalmology, Egypt (Other)
60
1
2
5
12.1

Study Details

Study Description

Brief Summary

To compare the efficacy and efficiency of peribulbar block versus sub-Tenon's capsule injection of local anesthetic in redo vitreoretinal surgery

Condition or Disease Intervention/Treatment Phase
  • Procedure: peribulbar block versus subtenon's block
N/A

Detailed Description

Sixty patients undergoing vitreoretinal surgery were randomized to receive either peribulbar or sub-Tenon's capsule injection of 8 ml of a 20:80 mixture of 2% lidocaine and 0.5% bupivacaine with 60 IU hyalouronic acid.

The primary outcome measured was intraoperative eye pain, which was rated by patients in both groups using an 11-point (0-10) numerical visual analogue scale immediately after.

The surgeons indicated whether they perceived patient discomfort during 4 different stages of the operation: opening of the conjunctiva, vitrectomy (if performed), placement of scleral buckle (if performed) or using the laser probe, and closing of the conjunctiva.

The need for supplemental local anesthesia, and use of IV sedation for additional pain control intraoperatively were compared between the two groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Comparative Study Between Peribulbar Block Technique and Sub-Tenon's Technique in Adult Patients Undergoing Redo Vitreoretinal Surgery: RCT
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jul 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: subtenon's block

we use the subtenon cannula to inject the local anesthetic mixture

Procedure: peribulbar block versus subtenon's block
Sixty patients undergoing vitreoretinal surgery were randomized to receive either peribulbar or sub-Tenon's capsule injection of 8 ml of a 20:80 mixture of 2% lidocaine and 0.75% bupivacaine with 60 IU hyalouronic acid. two groups 30 patient each (group p and group s) after connecting the patient to the monitor, we give him sedation 50 mg propofol, apply a nasal cannula group P: receives 2 injection peribulbar block group S: receives single injection subtenon Patients rate their pain sensation in both groups using an 11-point (0-10) numerical visual analogue scale immediately after surgery.

Experimental: peribulbar block

we use the usual 25G sharp needle to inject the local anesthetic mixture

Procedure: peribulbar block versus subtenon's block
Sixty patients undergoing vitreoretinal surgery were randomized to receive either peribulbar or sub-Tenon's capsule injection of 8 ml of a 20:80 mixture of 2% lidocaine and 0.75% bupivacaine with 60 IU hyalouronic acid. two groups 30 patient each (group p and group s) after connecting the patient to the monitor, we give him sedation 50 mg propofol, apply a nasal cannula group P: receives 2 injection peribulbar block group S: receives single injection subtenon Patients rate their pain sensation in both groups using an 11-point (0-10) numerical visual analogue scale immediately after surgery.

Outcome Measures

Primary Outcome Measures

  1. intraoperative pain [during whole surgery duration (around 2 hours)]

    11 point verbal rating score from 0 to 10 where 0 is no pain and 10 is intolerable pain patient will be asked immediately after surgery about pain the need for intraoperative sedation will be recorded

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age between 18 and 80
Exclusion Criteria:
  • Uncooperative patients

  • Bleeding disorders

  • High axial length (30mm) with previous buckle surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Institute of Ophthalmology Giza Egypt

Sponsors and Collaborators

  • Abeer Samir Salem
  • Research Institute of Ophthalmology, Egypt

Investigators

  • Principal Investigator: Abeer Samir, MD, research institute of ophthalmology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abeer Samir Salem, Researcher of anesthesia, Research Institute of Ophthalmology, Egypt
ClinicalTrials.gov Identifier:
NCT04978415
Other Study ID Numbers:
  • subtenon's RIO
First Posted:
Jul 27, 2021
Last Update Posted:
Mar 2, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 2, 2022